Page 34 - Sanket Koul

HMPV scare: Centre asks states to enhance surveillance, create awareness

Seven HMPV cases detected in India; health secretary says country prepared for any potential surge in respiratory illness cases

HMPV outbreak: India reports 5 cases, govt says there's no need to panic

Health Min says current data shows no unusual surge in influenza-like respiratory illnesses

No unusual rise in flu-like cases in India, says govt amid China HMPV surge

Health Ministry convenes monitoring group meeting over hMPV surge in China

MSME Pharma units get breather as govt extends Schedule M deadline

Pharma cos with turnover of Rs 250 cr or less can submit an application to the central drugs regulator for one one-year extension

Budget wishlist: Pharma firms seek simplified taxes, stronger PLI scheme

Among other demands is the removal of Section 194R related to marketing samples that would ease business operations

No cause for alarm: Indian health officials on hMPV spread in China

The National Centre for Disease Control (NCDC) is also monitoring respiratory and seasonal influenza cases, official sources told news agency ANI

CDSCO, WB drugs body seize spurious drugs worth Rs 6.6 Cr in Kolkata

Anti-cancer, anti-diabetic drugs, labelled as manufactured in various countries, among those recovered without any supporting documents

Budget: Experts push for higher health, edu fund, duty cuts on cancer care

A key demand discussed in the meeting was the reduction of customs duty and other levies on the import of radiation machines used to treat cancer

Mankind Pharma inks pact with Innovent for immunotherapy drug in India

Drug used to treat non-small cell lung cancer, liver cancer, gastric cancer, esophageal cancer, endometrial cancer and Hodgkin's lymphoma will be priced competitively

CDSCO flags 2 drugs as spurious, another 111 fail quality test in Nov '24

While the CDSCO alert has named the brands for which they found spurious samples, the alert, however, does not name the drugmakers

Budget wishlist: Hospitals want rise in allocation, better PMJAY rates

According to the Nathealth-Healthcare Federation of India, the sector is pushing for an increase in healthcare spending to 2.5 per cent of the GDP

Action likely against AbbVie executive who signed self-declaration

Pharma cos and docs say medical conferences have declined since March after UCPMP was notified

Pharma dept reprimands AbbVie Healthcare for unethical marketing practices

Company sponsored 'extravagant pleasure trips' abroad of 30 doctors, violating code on pharmaceutical marketing practices

Centre mulls adding more Centres of Excellence for rare disease patients

2-3 new CoEs likely to be added to the current count of 12

IITs report rise in job offers, international placements in Phase-1

Commenting on the ongoing placement season, Prof Naresh Varma Datla, professor-in-charge, Office of Career Services (OCS) at IIT-D, said that the institute has had a very good start

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

The ceiling prices of seven other drugs were revised to include the impact of the 0.00551 per cent increase in drug prices in the National List of Essential Medicines

Nadda meets CMs, urges support for Centre's intensified TB campaign

Nadda called on CMs, lieutenant governors, state health ministers to monitor the campaign at state level and ensure the same is done by political and administrative leadership at the district level

Respiratory drug sales surge as pollution, monsoon drive higher demand

Sales in the respiratory market reached Rs 1,638 crore in November 2024, up from Rs 1,522 crore recorded in October 2024, amid a surge in pollution-related illnesses last month

DBT, CSCR develop 1st human gene therapy for Haemophilia A in India

Haemophilia is a severe bleeding disorder caused by the deficiency of clotting Factor VIII, leading to spontaneous internal and external bleeding episodes

Dr Morepen launches weight management product, forays into wellness biz

Company eyes Rs 30 crore revenue in first year, Rs 200 crore by 2030